nejm glp 1 Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential NEJM Clinician: Should we hold

The full picture isn't complete

Oxidation of LDL by recombinant human 15-lipoxygenase: evidence for alpha-tocopherol-dependent oxidation of esterified core and surface lipids

Safety Considerations: GLP-1 and Thyroid Medication Interactions GLP-1 medications do not directly interact with levothyroxine or other thyroid replacement drugs at the biochemical level

Choosing the right foods on semaglutide involves prioritizing protein to prevent muscle loss during weight reduction, eating smaller meals to accommodate reduced appetite and slowed gastric emptying, and avoiding foods that exacerbate GI side effects

Zhao X, Jin L, Liu Y, Liu Z,Liu Q

The elevation of these antioxidant compounds suggests that both substances may help protect against oxidative stress in the brain, though glutathione showed some interesting age-dependent effects that warrant further investigation